Skip to content
May 06, 2024

Equity.Guru

Investment information for the new generation

Search

low molecular weight heparin

Valeo Pharma’s (VPH.C) low molecular weight heparin (LMWH) drug, Redesca and Redesca HP, is now eligible for public reimbursement in seven provinces and territories across Canada, as well as…